This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe
Attend Our Hybrid Event on 5-8 December 2022!
Beurs van BerlageAmsterdam

Attend Our Hybrid Event on 5-8 December 2022!
Beurs van Berlage,
Amsterdam

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUND BREAKING MANUFACTURING, COMMERCIALISATION & SUPPLY CHAIN STRATEGIES

World renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs

Cell & Gene Therapy Manufacturing & Commercialization Europe 2022 Dates Announced!

Thank you to all who attended our CGT Europe 2021 Digital Week webinar series!  Our team is now look forward to CGT Europe 2022, which will be delivered as a hybrid event on 5-8 December 2022 in Amsterdam. 

Stay up to date on agenda and early registration announcements by signing up for email updates below.

Are you interested in speaking at this event? Speaker submission forms are due on 17 June 2022! Topics of this event include: Cell Therapy, Gene Edited Ex Vivo Cell Therapy, In Vivo Gene Therapy, Tissue Engineering, Manufacturing & Process Development, Analytics - Characterization & Validation, Raw Material, Viral Vectors & Supply Chain Logistics, Cryopreservation, and Partnering, Investment and Market Access. Apply today!

Key Topics Covered at Cell & Gene Therapy Europe

Cell Therapy

  • Push the boundaries of process development with novel considerations & strategies
  • Transition to a more standardizes approach to raw material selection & supply
  • Improve confidence in your supply chain with next generation manufacturing and cryo techniques

Gene Edited Ex Vivo Cell Therapy

  • Build a strategy for next generation allogeneic CAR & T cell therapies
  • Get to grips with different manufacturing infrastructures & commercialization strategies
  • Understand effective testing, characterization & validation approaches

In Vivo Gene Therapy

  • Optimize next generation cell lines and address the current challenges with viral vectors
  • Work towards continuous bioprocessing of vectors with enabling manufacturing tech
  • Ensure high throughput applications in downstream processing

CONNECT WITH KEY BUYERS AT CELL & GENE THERAPY EUROPE 2022

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247